Advertisement

Table of Contents

May 23, 2019; 133 (21)

BLOOD COMMENTARIES

PLENARY PAPER

BLOOD SPOTLIGHT

HOW I TREAT

IMMUNOBIOLOGY AND IMMUNOTHERAPY

MYELOID NEOPLASIA

  • NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML
    NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML
    Daniel Sasca, Jakub Szybinski, Andrea Schüler, Viral Shah, Jan Heidelberger, Patricia S. Haehnel, Anna Dolnik, Oliver Kriege, Eva-Marie Fehr, Wolf H. Gebhardt, George Reid, Claudia Scholl, Matthias Theobald, Lars Bullinger, Petra Beli and Thomas Kindler
  • Myelofibrosis osteoclasts are clonal and functionally impaired
    Myelofibrosis osteoclasts are clonal and functionally impaired
    Ivo Veletic, Taghi Manshouri, Asha S. Multani, C. Cameron Yin, Lei Chen, Srdan Verstovsek and Zeev Estrov

PLATELETS AND THROMBOPOIESIS

RED CELLS, IRON, AND ERYTHROPOIESIS

LETTER TO BLOOD

BLOOD WORK